细胞外乳酸通过在低氧条件下调节H3K9乳酸和SnoN表达来改善神经发生
Wenhong Xu1, Anqi Zhao1, Rui Han2
1The Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, China.
Stem cell research & therapy
|August 27, 2025
概括
在低氧状态下,L-乳酸通过基因素乳化 (H3K9la) 和SnoN蛋白促进神经发生. 这种途径突出了神经恢复的潜在治疗目标.
科学领域:
- 神经科学
- 生物化学
- 干细胞生物学
背景情况:
- 乳酸有利于成人的神经发生,并调解蛋白质的乳化.
- 基因素乳化在神经发生过程中的作用尚不清楚.
- 研究乳酸对神经干细胞 (NSC) 和基因素乳化的影响至关重要.
研究的目的:
- 解释乳酸和NSC命运之间的关系.
- 在神经发生过程中探索基因素乳酸的作用.
主要方法:
- 在低毒性条件下用乳酸治疗NSC.
- 使用了西斑,免疫光,RNA测序和ChIP测序.
- 分析了基因表达的变化.
主要成果:
- 在低氧状态下,L- 乳酸促进了神经发生,并诱导了H3K9 histone乳化 (H3K9la).
- 抑制L-乳酸或H3K9la会影响神经元发育和NSC分化.
- H3K9la在SnoN促进体中得到丰富,并且SnoN抑制降低了双丁 (DCX) +神经元的产生.
结论:
- 在低氧条件下,L-乳酸通过H3K9la/SnoN途径促进神经发生.
- SnoN被认为是乳酸诱导神经发生的关键媒介.
- H3K9la/SnoN轴是神经恢复的潜在治疗点,特别是在脑缺血中.
相关概念视频
Histone Modification
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


